Novartis CEO Vas Narasimhan (L) and Pfizer CEO Albert Bourla (Akio Kon/Bloomberg via Getty Images; Hannes P Albert/picture-alliance/dpa/AP Images)

Pfiz­er and No­var­tis chiefs lead phar­ma's CEO in­flu­encers on so­cial me­dia, analy­sis finds

When it comes to phar­ma CEOs as so­cial in­flu­encers, Pfiz­er’s Al­bert Bourla is a per­fect 10 com­pared to his peers.

No­var­tis CEO Vas Narasimhan is a close sec­ond, though, with a 9.2 so­cial im­pact rat­ing — and his sta­tus is on the rise, ac­cord­ing to Cre­ation Health­care’s new analy­sis of phar­ma CEO so­cial in­flu­ence.

The Cre­ation Health­care analy­sis com­pared phar­ma lead­ers against each oth­er based on the num­ber of fol­low­ers, fre­quen­cy of posts, num­ber of likes re­ceived, and the num­ber of com­ments, both by the CEO and from read­ers, across so­cial me­dia chan­nels. LinkedIn was by far the most pop­u­lar plat­form for phar­ma CEOs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.